In addition to PDAC, other cancers in humans, such as colorectal adenocarcinomas (CRACs) and lung adenocarcinomas (LUACs), also harbor a high prevalence of KRAS mutations [9]. The gene discussed is KRAS; the disease is lung adenocarcinoma.